Monogenic diabetes: Old and new approaches to diagnosis

Journal article

Up to 5% of young adults diagnosed with diabetes have a monogenic aetiology, the most common of which is maturity-onset diabetes of the young (MODY). A definitive molecular diagnosis is important, as this affects treatment, prognosis and family screening. Currently, however, rates of diagnosis are low due to a combination of lack of awareness of the benefits of making the diagnosis and the challenges of differentiating patients with MODY from those with common forms of diabetes. This article aims to introduce general physicians to the characteristics of monogenic diabetes and the clinical features that can be used to diagnose patients. Recently, genomewide association studies have resulted in the identification of C-reactive protein and glycan profile as specific biomarkers for the most common MODY subtype due to HNF1A mutations, and the potential translation of these findings are discussed. © Royal College of Physicians, 2013.

Authors: Owen, K

• Journal: Clinical Medicine, Journal of the Royal College of Physicians of London
• Volume: 13
• Issue: 3
• Pages: 278-281
• Publication date: 2013-06-01
• DOI: 10.7861/clinmedicine.13-3-278
• EISSN: 1473-4893
• ISSN: 1470-2118
• Language: English
• Keywords: Hnf1a; Maturity-onset diabetes of the young (mody); Monogenic diabetes; Aetiology of diabetes; Glycolytic enzyme glucokinase (gck)